CLOSED - Clinical Trial on NASH & Fibrosis Varies

Description

A local research facility is seeking participants aged 18-80 for a clinical research study on NASH and Fibrosis. This study is testing an investigational injectable medication for the treatment of Non-Alcoholic Steatohepatitis (NASH), newly known as Metabolic Dysfunction Associated Steatohepatitis (MASH) and Fibrosis.

Total participation will last approximately 3 years and 4 months, including 14 doctor’s visits and 4 phone visits throughout the study.

Trial-related procedures and study medication will be provided at no cost.

Space is limited, subject to availability. Criteria for qualification are subject to change at any time and without notice.